| Year |
Citation |
Score |
| 2023 |
Ekman S, Cselényi Z, Varrone A, Jucaite A, Martin H, Schou M, Johnström P, Laus G, Lewensohn R, Brown AP, van der Aart J, Vishwanathan K, Farde L. Brain exposure of osimertinib in patients with EGFRm NSCLC and brain metastases: a PET and MRI study. Clinical and Translational Science. PMID 36808835 DOI: 10.1111/cts.13500 |
0.378 |
|
| 2022 |
Mattsson P, Cselényi Z, Andrée B, Borg J, Nag S, Halldin C, Farde L. Decreased 5-HT binding in mild Alzheimer's disease-A positron emission tomography study. Synapse (New York, N.Y.). 76: e22235. PMID 35587913 DOI: 10.1002/syn.22235 |
0.327 |
|
| 2021 |
Veldman ER, Varrone A, Varnäs K, Svedberg MM, Cselényi Z, Tiger M, Gulyás B, Halldin C, Lundberg J. Serotonin 1B receptor density mapping of the human brainstem using positron emission tomography and autoradiography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X211049185. PMID 34644198 DOI: 10.1177/0271678X211049185 |
0.584 |
|
| 2020 |
Jucaite A, Stenkrona P, Cselényi Z, De Vita S, Buil-Bruna N, Varnäs K, Savage A, Varrone A, Johnström P, Schou M, Davison C, Sykes A, Reddy VP, Hoch M, Vazquez-Romero A, et al. Brain exposure of the ATM inhibitor AZD1390 in humans - a positron emission tomography (PET) study. Neuro-Oncology. PMID 33123736 DOI: 10.1093/neuonc/noaa238 |
0.364 |
|
| 2019 |
Varnäs K, Cselényi Z, Arakawa R, Nag S, Stepanov V, Moein MM, Johnström P, Kingston L, Elmore CS, Halldin C, Farde L. The pro-psychotic metabotropic glutamate receptor compounds fenobam and AZD9272 share binding sites with monoamine oxidase-B inhibitors in humans. Neuropharmacology. 107809. PMID 31589885 DOI: 10.1016/J.Neuropharm.2019.107809 |
0.326 |
|
| 2019 |
Varrone A, Varnäs K, Jucaite A, Cselényi Z, Johnström P, Schou M, Vazquez-Romero A, Moein MM, Halldin C, Brown AP, Vishwanathan K, Farde L. A PET study in healthy subjects of brain exposure of C-labelled osimertinib - A drug intended for treatment of brain metastases in non-small cell lung cancer. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X19843776. PMID 31006308 DOI: 10.1177/0271678X19843776 |
0.459 |
|
| 2019 |
Schou M, Ewing P, Cselenyi Z, Fridén M, Takano A, Halldin C, Farde L. Pulmonary PET imaging confirms preferential lung target occupancy of an inhaled bronchodilator. Ejnmmi Research. 9: 9. PMID 30694407 DOI: 10.1186/S13550-019-0479-8 |
0.301 |
|
| 2019 |
Ekman S, Varrone A, Jucaite A, Vishwanathan K, Brown A, Cselényi Z, Martin H, Lewensohn R, Schou M, Laus G, Van Der Aart J, Johnström P, Singh N, Farde L. P2.14-33 An Open-Label PET-MRI Study to Determine Brain Exposure of Osimertinib in Patients with EGFR Mutant NSCLC and CNS Metastases Journal of Thoracic Oncology. 14: S842. DOI: 10.1016/j.jtho.2019.08.1818 |
0.304 |
|
| 2018 |
Plavén-Sigray P, Matheson GJ, Cselényi Z, Jucaite A, Farde L, Cervenka S. Test-retest reliability and convergent validity of (R)-[C]PK11195 outcome measures without arterial input function. Ejnmmi Research. 8: 102. PMID 30498919 DOI: 10.1186/s13550-018-0455-8 |
0.551 |
|
| 2017 |
Matheson GJ, Stenkrona P, Cselényi Z, Plavén-Sigray P, Halldin C, Farde L, Cervenka S. Reliability of Volumetric and Surface-Based Normalisation and Smoothing Techniques for PET Analysis of the Cortex: A Test-Retest Analysis using [(11)C]SCH-23390. Neuroimage. PMID 28419852 DOI: 10.1016/J.Neuroimage.2017.04.031 |
0.573 |
|
| 2015 |
Matheson GJ, Schain M, Almeida R, Lundberg J, Cselényi Z, Borg J, Varrone A, Farde L, Cervenka S. Diurnal and seasonal variation of the brain serotonin system in healthy male subjects. Neuroimage. 112: 225-31. PMID 25772667 DOI: 10.1016/J.Neuroimage.2015.03.007 |
0.59 |
|
| 2014 |
Schain M, Varnäs K, Cselényi Z, Halldin C, Farde L, Varrone A. Evaluation of two automated methods for PET region of interest analysis. Neuroinformatics. 12: 551-62. PMID 24880728 DOI: 10.1007/S12021-014-9233-6 |
0.33 |
|
| 2014 |
Schou M, Varnäs K, Sandell J, Johnström P, Cselenyi Z, Svensson S, Nakao R, Amini N, Bergman L, Sumic A, Gulyas B, Lindström-Böö E, Halldin C, Farde L. Synthesis, radiolabeling, and in vivo pharmacokinetic evaluation of the amyloid beta radioligand [11C]AZD4694 in nonhuman primates. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 16: 173-9. PMID 24002613 DOI: 10.1007/S11307-013-0666-3 |
0.607 |
|
| 2013 |
Forsberg A, Juréus A, Cselényi Z, Eriksdotter M, Freund-Levi Y, Jeppsson F, Swahn BM, Sandell J, Julin P, Schou M, Andersson J, Johnström P, Varnäs K, Halldin C, Farde L, et al. Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patients. European Journal of Nuclear Medicine and Molecular Imaging. 40: 580-93. PMID 23324871 DOI: 10.1007/S00259-012-2322-6 |
0.312 |
|
| 2013 |
Jucaite A, Cselényi Z, Varrone A, Varnäs K, Johnström P, Halldin C, Salter H, McLoughlin M, Rinne J, Svenningsson P, Alexander R, Kugler A, Farde L. 145. Translocator protein (TSPO) as a biomarker of microglia activation: PET imaging using [11C]PBR28 in Parkinson’s disease Brain, Behavior, and Immunity. 32: e42. DOI: 10.1016/J.Bbi.2013.07.157 |
0.397 |
|
| 2012 |
Ju?aite A, Cselényi Z, Arvidsson A, Ahlberg G, Julin P, Varnäs K, Stenkrona P, Andersson J, Halldin C, Farde L. Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects. Ejnmmi Research. 2: 15. PMID 22524272 DOI: 10.1186/2191-219X-2-15 |
0.346 |
|
| 2010 |
Cselényi Z, Jönhagen ME, Forsberg A, Halldin C, Julin P, Schou M, Johnström P, Varnäs K, Svensson S, Farde L. Quantification and wavelet-aided parametric imaging of cerebral amyloid using the HRRT PET-system and [18F]AZD4694 Neuroimage. 52: S142. DOI: 10.1016/J.Neuroimage.2010.04.116 |
0.307 |
|
| 2008 |
Vas A, Shchukin Y, Karrenbauer VD, Cselényi Z, Kostulas K, Hillert J, Savic I, Takano A, Halldin C, Gulyás B. Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients. Journal of the Neurological Sciences. 264: 9-17. PMID 17727889 DOI: 10.1016/J.Jns.2007.07.018 |
0.64 |
|
| 2004 |
McCarron JA, Pike VW, Halldin C, Sandell J, Sóvágó J, Gulyas B, Cselényi Z, Wikström HV, Marchais-Oberwinkler S, Nowicki B, Dollé F, Farde L. The pyridinyl-6 position of WAY-100635 as a site for radiofluorination--effect on 5-HT1A receptor radioligand behavior in vivo. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 6: 17-26. PMID 15018825 DOI: 10.1016/J.Mibio.2003.12.001 |
0.708 |
|
| 2002 |
Vas A, Sóvágó J, Halldin C, Sandell J, Karlsson P, Kárpáti E, Kiss B, Cselényi Z, Farde L, Gulyás B. [Cerebral uptake and regional distribution of [11C]-vinpocetin after intravenous administration to healthy men: a PET study]. Orvosi Hetilap. 143: 2631-6. PMID 12532649 |
0.738 |
|
| 2002 |
Gulyás B, Halldin C, Sandell J, Karlsson P, Sóvágó J, Kárpáti E, Kiss B, Vas A, Cselényi Z, Farde L. PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects. Acta Neurologica Scandinavica. 106: 325-32. PMID 12460136 DOI: 10.1034/J.1600-0404.2002.01302.X |
0.729 |
|
| 2002 |
Gulyás B, Halldin C, Sóvágó J, Sandell J, Cselényi Z, Vas A, Kiss B, Kárpáti E, Farde L. Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine. European Journal of Nuclear Medicine and Molecular Imaging. 29: 1031-8. PMID 12173017 DOI: 10.1007/S00259-002-0823-4 |
0.711 |
|
| 2001 |
Cselényi Z, Olsson H, Gulyás B, Halldin C, Farde L. Detailed mapping of dopamine D2 receptors in the human limbic system using FLB 457 binding analysis in wavelet space Neuroimage. 13: 1299. DOI: 10.1016/S1053-8119(01)92613-8 |
0.423 |
|
| 2001 |
Sandell J, Yu M, Emond P, Gulyas B, Cselenyi Z, Sovago J, Garreau L, Hall H, Chalon S, Guilloteau D, Någren K, Farde L, Halldin C. Radiolabeling, preliminary biological evaluation and pet examination in monkey of 5-methyl-6-nitroquipazine - a potential serotonin transporter radioligand Journal of Labelled Compounds and Radiopharmaceuticals. 44: S170-S172. DOI: 10.1002/JLCR.2580440159 |
0.671 |
|
| 2001 |
Sandell J, Mccarron JA, Halldin C, Pike VW, Gulyas B, Cselenyi Z, Sovago J, Marchais S, Wikström HV, Farde L. [18F]6FPWAY - a prospective 5-HT1A receptor radioligand - radiolabeling and pet examination in monkey - comparison with [11C]6FPWAY Journal of Labelled Compounds and Radiopharmaceuticals. 44: S167-S169. DOI: 10.1002/Jlcr.2580440158 |
0.699 |
|
| Show low-probability matches. |
